Mechanisms of the inhibition of t-PA by PAI-1
PAI-1抑制t-PA的机制
基本信息
- 批准号:62570040
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1987
- 资助国家:日本
- 起止时间:1987 至 1989
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have developed an enzyme immunoassay for the measurements of fibrinolytic parameters such as tissue plasminogen activator (t-PA) and urokinase (UK). A silicone piece coupled with first antibody was incubated with a sample. After incubation the silicone piece was washed and then incubated with a solution containing beta-D-galactosidase labeled second antibody. The activity of beta-D-galactosidase was measured. Using a monoclonal antibody against PAI-1 as a first antibody and beta-D-galactosidase labeled anti- t-PA Fab' fragments as a second antibody, we developed a new assay system to measure the concentrations of total PAI-1, free PAI-1 and t-PA-PAI-1 complex. The amounts of t-PA-PAI-1 complex were measured from the plasma, and those of total PAI-1 were measured from plasma preincubated with t-PA, and those of free PAI-1 were obtained by subtractions of the amounts of t-PA-PAI-1 complex from those of total PAI-1. Plasma levels of t-PA and t-PA-PAI-1 complex increased with increase in age. Plasma levels of t-PA were higher in males than in females, and those in females gradually increased with increase in age, reaching the same levels as those of males at their 60s. Plasma levels of t-PA-PAI-1 complex and free PAI-1 were also higher in males than in females. Then circadian rhythm (8:30, 10:30, 12:30, 14:30 and 16:30 h) of fibrinolysis was measured. Euglobulin lysis time (ELT) showed longest time at 8:30 to 10:30 h and shortest time at 16:30 h. ELT was always shorter in females than in males, The highest level of t-PA or free PAI-1 was obtained in the morning and the lowest was in the evening. These results indicate that the fibrinolytic parameters were balanced at higher levels in plasma in males than in females, but the fibrinolytic activity was higher in females than in males.
我们已经开发了一种酶免疫测定法,用于测量纤溶参数,如组织型纤溶酶原激活剂(t-PA)和尿激酶(UK)。将与第一抗体偶联的硅胶片与样品一起孵育。孵育后,洗涤硅胶片,然后与含有β-D-半乳糖苷酶标记的第二抗体的溶液一起孵育。测定β-D-半乳糖苷酶的活性。以抗派-1单克隆抗体为第一抗体,β-D-半乳糖苷酶标记的抗t-PA Fab'片段为第二抗体,建立了一种新的测定总派-1、游离派-1和t-PA-派-1复合物浓度的方法。从血浆中测量t-PA-派-1复合物的量,从用t-PA预孵育的血浆中测量总派-1的量,通过从总派-1的量中减去t-PA-派-1复合物的量获得游离派-1的量。血浆t-PA和t-PA-派-1复合物水平随年龄增长而升高。男性血浆t-PA水平高于女性,女性随年龄增长逐渐升高,60多岁时达到与男性相同的水平。男性t-PA-派-1复合物和游离派-1的血浆水平也高于女性。然后测定纤溶昼夜节律(8:30、10:30、12:30、14:30和16:30 h)。优球蛋白溶解时间(ELT)在8:30 ~ 10:30 h最长,16:30 h最短。女性ELT均短于男性,t-PA和游离派-1水平在早晨最高,晚上最低。这些结果表明,男性血浆中的纤溶参数平衡水平高于女性,但女性的纤溶活性高于男性。
项目成果
期刊论文数量(89)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takada,A.: "Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources" Haemostasis. 18. 117-125 (1988)
Takada,A.:“从不同来源获得的组织纤溶酶原激活剂激活谷氨酸纤溶酶原的动力学参数的比较”止血。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishino,N.: "Measurement of urinary trypsin inhibitor in urine,plasma and cancer tissues of patients with stomach cancer" Haemostasis. 19. 112-119 (1989)
Nishino,N.:“胃癌患者尿液、血浆和癌组织中尿胰蛋白酶抑制剂的测量”止血。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakakibara,K.: "Urinary UK,t-PA and urinaty trypsin inhibitor in health and glomerular diseases" Thrombosis Research. 56. 239-249 (1989)
Sakakibara,K.:“尿英国、t-PA 和尿胰蛋白酶抑制剂在健康和肾小球疾病中的作用”血栓研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takada Y; Takada A: "Evidence for the formation of a trimolecular complex between streptokinase, plasminogen and fibrinogen" Thromb. Res.53(4). 409-415 (1989)
高田Y;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takada Y; Takada A: "Plasma levels of t-PA, free PAI-1 and a complex of t-PA with PAI-1 in human males and females at various ages." Thromb. Res.55(5). 601-609 (1989)
高田Y;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKADA Y.其他文献
TAKADA Y.的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKADA Y.', 18)}}的其他基金
Theoretical Research of Statistical Inference by Multi-Stage Procedures
多阶段程序统计推断的理论研究
- 批准号:
15500188 - 财政年份:2003
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of rapid diagnosis of enteric infections
肠道感染快速诊断的研究
- 批准号:
05044160 - 财政年份:1993
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
Tissue plasminogen activator for the treatment of glaucoma
用于治疗青光眼的组织纤溶酶原激活剂
- 批准号:
10642977 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Laser-induced Choroidal Neovascular ization in Mice
组织纤溶酶原激活剂作为实验性激光诱导小鼠脉络膜新生血管形成的抗血管生成剂
- 批准号:
16K20323 - 财政年份:2016
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Mechanism of production and release of tissue plasminogen activator in airway epithelial cells
气道上皮细胞组织纤溶酶原激活剂的产生和释放机制
- 批准号:
15K10779 - 财政年份:2015
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of tissue plasminogen activator administration on cholinergic and cognitive deficits in in a transgenic model of Alzheimer's disease-like amyloid pathology
组织纤溶酶原激活剂给药对阿尔茨海默病样淀粉样蛋白病理转基因模型中胆碱能和认知缺陷的影响
- 批准号:
311872 - 财政年份:2013
- 资助金额:
$ 1.22万 - 项目类别:
Studentship Programs
Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA trial)
胸腔内 DNase 和组织纤溶酶原激活剂治疗小儿脓胸(DTPA 试验)
- 批准号:
253540 - 财政年份:2012
- 资助金额:
$ 1.22万 - 项目类别:
Operating Grants
The Role of Tissue Plasminogen Activator in a Mouse Spinal Cord Injury Model
组织纤溶酶原激活剂在小鼠脊髓损伤模型中的作用
- 批准号:
8196811 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
the effect of tissue plasminogen activator and pitavastatin on the blood brain barrier
组织纤溶酶原激活剂和匹伐他汀对血脑屏障的影响
- 批准号:
21791371 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The Role of Tissue Plasminogen Activator in a Mouse Spinal Cord Injury Model
组织纤溶酶原激活剂在小鼠脊髓损伤模型中的作用
- 批准号:
8005539 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
The Role of Tissue Plasminogen Activator in a Mouse Spinal Cord Injury Model
组织纤溶酶原激活剂在小鼠脊髓损伤模型中的作用
- 批准号:
7613869 - 财政年份:2009
- 资助金额:
$ 1.22万 - 项目类别:
Unique secretory dynamics of tissue plasminogen activator and vascular function
组织纤溶酶原激活剂和血管功能的独特分泌动力学
- 批准号:
19590858 - 财政年份:2007
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




